Kentucky AG Sues Teva for Promoting Off-Label Uses of Fentanyl Products

International Pharmaceutical Regulatory Monitor
A A
The state of Kentucky filed a lawsuit against Teva, alleging the drugmaker’s off-label promotion of two drugs for cancer pain has exacerbated the opioid epidemic.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00